UnknownNot Applicable

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

50 participantsStarted 2016-08

Plain-language summary

The purpose of this study is to compare two luteal support protocols in In vitro fertilization patients (IVF) and are at risk of developing ovarian hyperstimulation syndrome (OHSS). We would like to determine whether luteal Decapeptyl on days 3, 6,9 post ovulation triggering is as good as low dose hCG on day 3 post triggering..

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * IVF treatment * GnRH antagonist protocol * GnRH agonist triggering of ovulation * High risk for OHSS as expressed by either E2 serum level \>2500 pg/ml Exclusion Criteria: * background maternal morbidity * Any protocol other than GnRH antagonist protocol * hCG triggering of ovulation * E2 serum level \>4500 pg/ml * Aspiration of \>25 ova * Embryo transfer prior to day 5

What they're measuring

Progesterone serum level

Timeframe: day 5 post ovum pickup

Trial details

NCT IDNCT02827656

SponsorMeir Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-08

Contact for this trial

Anat Klement, MD

anat.klement@gmail.com

View on ClinicalTrials.gov More Infertility trials